Abrodil

Last revised by Andrew Murphy ◉ on 23 Mar 2023

Citation, DOI, disclosures and article data

Citation:

Bell D, Murphy A, Iqbal S, et al. Abrodil. Reference article, Radiopaedia.org (Accessed on 26 Sep 2023) https://doi.org/10.53347/rID-63289

DOI:

https://doi.org/10.53347/rID-63289

Permalink:

https://radiopaedia.org/articles/63289

rID:

63289

Article created:

23 Sep 2018, Daniel J Bell ◉

Disclosures:

At the time the article was created Daniel J Bell had no recorded disclosures.

View Daniel J Bell's current disclosures

Last revised:

23 Mar 2023, Andrew Murphy ◉

Disclosures:

At the time the article was last revised Andrew Murphy had no financial relationships to ineligible companies to disclose.

View Andrew Murphy's current disclosures

Revisions:

9 times, by 3 contributors - see full revision history and disclosures

Tags:

stub

Synonyms:

Skiodan
Sodium salt of monoiodomethanesulfonic acid

Abrodil (marketed as Skiodan in the US) was a water-based iodinated contrast medium introduced for clinical use in 1930 ³. It was developed by Bronner, Hecht and Schueller in Germany. Chemically, Abrodil is the sodium salt of monoiodomethanesulfonic acid.

It was initially employed for intravenous pyelography, but it became popular for myelography and first tried in 1931. It was commonly employed in Scandinavia but never gained traction elsewhere, primarily due to its associated headache, ocular pain and leptomeningeal irritation.